D-Cycloserine Enhancement of Exposure in Social Phobia

PHASE4CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

September 30, 2012

Conditions
Social Anxiety Disorder
Interventions
BEHAVIORAL

Cognitive Behavioral Group Therapy (CBGT)

The patient will then receive 12 weekly sessions of Cognitive Behavioral Therapy lasting approximately two and a half hours each. During these sessions, patients will receive information on the nature of social phobia and a model of treatment and will receive weekly training in how to become more comfortable with social situations, with the goal of achieving confidence in social interactions. As part of this training, the therapist will practice social interactions with the patient, who will also be asked to practice what they have learned outside of the therapists' office.

DRUG

D-Cycloserine

For the third, fourth, fifth, sixth, and seventh sessions of the twelve-session program of Cognitive Behavioral Therapy, the patient will be asked to arrive one hour early to take one of the study pill, a 50mg pill of d-cycloserine. A physician will be available in the unlikely event that a patient begins to experience side effects. Before the treatment starts, before the eighth session, and one week after the final session patients will have a separate visit in which their levels of symptoms assessed with measures of mood, anxiety, and avoidance.

DRUG

Placebo

For the third, fourth, fifth, sixth, and seventh sessions of the twelve-session program of Cognitive Behavioral Therapy, the patient will be asked to arrive one hour early to take one of the study pill, a placebo. A physician will be available in the unlikely event that a patient begins to experience side effects. Before the treatment starts, before the eighth session, and one week after the final session patients will have a separate visit in which their levels of symptoms assessed with measures of mood, anxiety, and avoidance.

Trial Locations (1)

02114

Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Boston University

OTHER

collaborator

Southern Methodist University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00633984 - D-Cycloserine Enhancement of Exposure in Social Phobia | Biotech Hunter | Biotech Hunter